Instrument dashboard

LOGITECH INTERNATIONAL S.A. (LOGI)

NASDAQ · US

LOGI · Market chart

Loading chart…

Latest Pine script: 2026-11-19

Market structure

PRICE LEVEL INTELLIGENCE

Reference close · 2026-11-20
LEVEL / SOURCEPRICE LEVELPRICE
Primary Rising Wedge LowerTECHNICAL · Anchors: 2025-04-08 low 64.73 and 2026-06-30 low 91.32. x is elapsed 24-hour periods since 2025-04-08 00:00 America/New_York; y is price. The fixed line extends right as the rising lower boundary. Its projection on 2026-11-18 is approximately 99.69. The latest close of 101.01 is above the projected boundary, making it current structural support.
—
Primary Rising Wedge UpperTECHNICAL · Anchors: 2025-11-03 high 123.01 and 2026-06-02 high 129.66. x is elapsed 24-hour periods since 2025-11-03 00:00 America/New_York; y is price. The fixed line extends right as the rising upper boundary. Together with the lower rising boundary, the two lines converge over their shared interval, supporting a rising-wedge formation. Its projection on 2026-11-18 is approximately 134.99, above the latest close of 101.01, making it overhead structural resistance.
—
Secondary Descending TrendlineTECHNICAL · Anchors: 2021-09-07 high 104.28 and 2022-03-29 high 78.96. x is elapsed 24-hour periods since 2021-09-07 00:00 America/New_York; y is price. The fixed segment ends on 2022-03-29 and is not extended. Historical high interactions near 2021-09-10, 2021-09-23, 2022-01-05, 2022-01-11 and 2022-03-28/29 support the descending resistance trajectory.
—
ATR1 SupportTECHNICAL · Derived from the significant 2026-01-28 control bar, with low 83.32 and high 91.14. True range was 10.42 against Wilder ATR(14) of approximately 2.95, a ratio of 3.53. The region contains the traditional S1 pivot at 89.08, while the rising structural lower boundary projects approximately 82.24 on the control-bar date, near its lower boundary. The latest close of 101.01 is above the region, making it support.
83.32 – 91.14
ATR2 SupportTECHNICAL · Derived from the significant 2026-03-17 control bar, with low 91.28 and high 97.89. True range was 6.61 against Wilder ATR(14) of approximately 2.80, a ratio of 2.36. Its lower boundary aligns within 0.04 of the independently established broad structural range lower boundary at 91.32. The latest close of 101.01 is above the region, making it support.
91.28 – 97.89
Range DisputedTECHNICAL · The fixed lower boundary is the 2026-06-30 low of 91.32. The fixed upper boundary is the 2026-10-22 high of 113.06. These boundaries define the broad trading range represented by the horizontal dashed lines and translucent fill. The 2026-11-18 close of 101.01 is inside the region, making its current role disputed.
91.32 – 113.06
ATR5 DisputedTECHNICAL · Derived from the significant 2026-10-28 control bar, with low 97.61 and high 102.56. True range was 14.21 against Wilder ATR(14) of approximately 3.83, a ratio of 3.71. The region contains the independently calculated October traditional central pivot at 101.07. The latest close of 101.01 is inside the region, making its current role disputed.
97.61 – 102.56
ATR3 ResistanceTECHNICAL · Derived from the significant 2026-05-22 control bar, with low 106.92 and high 113.04. True range was 7.24 against Wilder ATR(14) of approximately 3.52, a ratio of 2.06. Its upper boundary aligns within 0.02 of the independently established broad structural range upper boundary at 113.06. The latest close of 101.01 is below the region, making it resistance.
106.92 – 113.04
ATR4 ResistanceTECHNICAL · Derived from the significant 2026-05-29 control bar, with low 117.35 and high 123.57. True range was 11.81 against Wilder ATR(14) of approximately 4.00, a ratio of 2.95. The region contains the independently calculated October traditional R2 pivot at 119.51. The latest close of 101.01 is below the region, making it resistance.
117.35 – 123.57
Oct 2026 S2 82.63TECHNICAL · Calculated from the completed October 2026 trading month using high 113.06, low 94.62 and close 95.53. The calculation is P-(H-L). The 2026-11-18 close of 101.01 is above this exact level, making it support.
82.63
Analyst 12-month low targetANALYST · Lowest analyst 12-month price target
84.00
Oct 2026 S1 89.08TECHNICAL · Calculated from the completed October 2026 trading month using high 113.06, low 94.62 and close 95.53. The calculation is 2P-H, where P is the traditional central pivot. The 2026-11-18 close of 101.01 is above this exact level, making it support.
89.08
Oct 2026 P 101.07TECHNICAL · Calculated from the completed October 2026 trading month using high 113.06 on 2026-10-22, low 94.62 on 2026-10-30 and close 95.53 on 2026-10-30. The calculation is (H+L+C)/3. The 2026-11-18 close of 101.01 is below this exact level, making it resistance.
101.07
Analyst 12-month median targetANALYST · Median analyst 12-month price target
107.50
Oct 2026 R1 107.52TECHNICAL · Calculated from the completed October 2026 trading month using high 113.06, low 94.62 and close 95.53. The calculation is 2P-L, where P is the traditional central pivot. The 2026-11-18 close of 101.01 is below this exact level, making it resistance.
107.52
Oct 2026 R2 119.51TECHNICAL · Calculated from the completed October 2026 trading month using high 113.06, low 94.62 and close 95.53. The calculation is P+(H-L). The 2026-11-18 close of 101.01 is below this exact level, making it resistance.
119.51
Analyst 12-month high targetANALYST · Highest analyst 12-month price target
141.00
GEX put wall · 2026-12-18GEX · Options positioning
95.00
GEX call wall · 2026-12-18GEX · Options positioning
110.00

Sign in to view price levels

Technical, analyst and options-derived levels are available to signed-in members.

Sign in
AI-Ready Research Pack

Download the available financial metrics, calculation methodology and latest technical price levels for LOGI.

Download research pack
Files included for this instrument:
  • SEC financial metrics calculation guide
  • Financial metrics for the current year
  • Technicals and future GEX levels
Company fundamentals

Financial health

Revenue••••••Profitability••••••Cash flow••••••Capital structure••••••
Available reporting years2027, 2026

Sign in to request beta access

Financial health insights are in a limited beta.

Sign in
Valuation framework

Valuation

Midpoint fair value••••••
Cash Flow DCF••••••
Revenue unit economics••••••
Reporting periods: 2 quarters available

Sign in to request beta access

Valuation tools are in a limited beta.

Sign in